Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Analysis of Cuproptosis-Related Genes in Prognosis and Immune Infiltration of Hepatocellular Carcinoma Based on Bulk and Single-Cell RNA Sequencing Data. | Cancers (Basel) | 2022 | 36428805 | PubTator, text mining | PubMed |
| SOX4 Mediates ATRA-Induced Differentiation in Neuroblastoma Cells. | Cancers (Basel) | 2022 | 36428735 | PubTator, text mining | PubMed |
| Naringin's Prooxidant Effect on Tumor Cells: Copper's Role and Therapeutic Implications. | Pharmaceuticals (Basel) | 2022 | 36422562 | PubTator, text mining | PubMed |
| Relationship between copper and immunity: The potential role of copper in tumor immunity. | Front Oncol | 2022 | 36419894 | PubTator, text mining | PubMed |
| Copper homeostasis and cuproptosis in health and disease. | Signal Transduct Target Ther | 2022 | 36414625 | PubTator, text mining | PubMed |
| Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis. | Front Oncol | 2022 | 36408192 | PubTator, text mining | PubMed |
| Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in Pancreatic Cancer. | Can J Gastroenterol Hepatol | 2022 | 36406148 | PubTator, text mining | PubMed |
| A panel of seven immune-related genes can serve as a good predictive biomarker for cervical squamous cell carcinoma. | Front Genet | 2022 | 36406134 | PubTator, text mining | PubMed |
| Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma. | Front Genet | 2022 | 36406128 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related genes in immune infiltration and diagnosis in ulcerative colitis. | Front Immunol | 2022 | 36389705 | PubTator, text mining | PubMed |
| The Cuproptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Tumour Immune Analysis in Osteosarcoma. | Comput Math Methods Med | 2022 | 36388161 | PubTator, text mining | PubMed |
| Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer. | Front Oncol | 2022 | 36387247 | PubTator, text mining | PubMed |
| Identification of molecular subtypes and a six-gene risk model related to cuproptosis for triple negative breast cancer. | Front Genet | 2022 | 36386788 | PubTator, text mining | PubMed |
| Association of Zn and Cu Levels in Cord Blood and Maternal Milk with Pregnancy Outcomes among the Slovenian Population. | Nutrients | 2022 | 36364931 | PubTator, text mining | PubMed |
| Curcumin and Its Derivatives Induce Apoptosis in Human Cancer Cells by Mobilizing and Redox Cycling Genomic Copper Ions. | Molecules | 2022 | 36364236 | PubTator, text mining | PubMed |
| Exosomes as New Generation Vehicles for Drug Delivery: Biomedical Applications and Future Perspectives. | Molecules | 2022 | 36364116 | PubTator, text mining | PubMed |
| Radiosensitization-Related Cuproptosis LncRNA Signature in Non-Small Cell Lung Cancer. | Genes (Basel) | 2022 | 36360316 | PubTator, text mining | PubMed |
| Transcriptome Analysis Reveals That SREBP Modulates a Large Repertoire of Genes Involved in Key Cellular Functions in Penaeus vannamei, although the Majority of the Dysregulated Genes Are Unannotated. | Genes (Basel) | 2022 | 36360293 | PubTator, text mining | PubMed |
| ATP7B-Deficient Hepatocytes Reveal the Importance of Protein Misfolding Induced at Low Copper Concentration. | Cells | 2022 | 36359796 | PubTator, text mining | PubMed |
| Role of protein phosphorylation in cell signaling, disease, and the intervention therapy. | MedComm (2020) | 2022 | 36349142 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=34